Formulations with AS03B (especially the 0.003 μg/dose) also generated more influenza-specific CD4+ and CD8+ T cells than the unadjuvanted or AS03A-adjuvanted vaccines, although these cells were primarily single positive for IFNγ. Here, CD4 is linked to influenza.